Join one of the leaders from PANTHERx® Specialty Pharmacy at the 15th annual Specialty Therapies Conference, January 25-26, in Las Vegas, Nevada.  The conference brings together payers, specialty pharmacies, and pharmaceutical representatives to discuss the challenges of paying for innovative therapies for the treatment of diseases.  Discussions focus on current issues in specialty therapy management, […]

PANTHERx® Chairman and CEO, Dr. Gordon J. Vanscoy, has been invited to join world business leaders at the 36th annual J.P. Morgan Healthcare Conference, January 8-11, at the Westin St. Francis in San Francisco.  Focused on companies that are shaping today and tomorrow’s healthcare industry, the conference brings together healthcare executives, representatives from dynamic, fast-growing organizations, technology innovators, and investors. […]

PANTHERx® Specialty Pharmacy is now stocking and dispensing an oral rinse indicated for the management of oral mucositis/stomatitis that may be caused by radiotherapy and/or chemotherapy. Oral mucositis therapies coat the oral mucosa that lines the mouth and throat forming a soothing, protective layer to reduce mouth and throat soreness associated with painful oral mucositis. […]

PANTHERx® Chairman and CEO, Gordon J. Vanscoy, was honored on October 12, 2017 with the highest honor bestowed by the University of Pittsburgh to its alumni, the University of Pittsburgh Distinguished Alumni Fellow Award. “Every professional opportunity that I pursued, I embarked on with a single purpose in mind, to innovate and improve the quality […]

PANTHERx® Specialty Pharmacy announced today that it has entered into a preferred partnership to provide certain acute care products and supportive services for Highmark members.  The partnership will ensure product availability, ancillary supplies, comprehensive patient education, and adherence support. “Highmark is excited to work with PANTHERx® as a way to advance our mission of offering […]